L3Harris Technologies enters its July 23 earnings report as the relative laggard in a defense sector that has had a strong week — and the gap between where the stock trades and where the Street thinks it should be deserves scrutiny.
The peer divergence is the week's clearest tension. NOC gained nearly 11% over the past five sessions. DRS climbed a similar 11%. RTX, LMT, and GD each added 6-8%. L3Harris managed a more modest 1.7% gain — and then gave back almost 2% on Tuesday alone. When the sector rips and a name barely participates, the market is making a statement about relative confidence ahead of the print.
The lending market offers no signal of unusual conviction on either side. Short interest is genuinely low — just 1.6% of the free float, and broadly flat on the week despite a 33% climb over the past month from a very small base. Borrow costs remain nearly free at under 0.5%, and availability is at maximum — well over 100 times current short interest. That rules out any squeeze dynamic. The shorts adding over the past month are doing so at essentially zero cost and face no pressure from the borrow side. Separately, options positioning is almost perfectly neutral, with the put/call ratio at 0.46, indistinguishable from its 20-day average. Neither the derivatives nor the lending market is pricing in any particular anxiety ahead of July 23.
The Street, by contrast, thinks the stock has meaningful room to recover. The analyst consensus mean target of $380 implies roughly 29% upside from the current $295. The most recent moves were cuts — Bernstein trimmed to $405 in early May and UBS dropped to $330 around the same time, both post-Q1 — but neither was a downgrade, and the broader tone from JPMorgan and Morgan Stanley (both Overweight/Outperform) remains constructive. The bull case centers on the Aerojet segment's 12% organic growth and a $200 million free cash flow guidance raise. Bears point to SAS margin compression — down 30 basis points to 12.3% — and softness in the Space business. The PE multiple has drifted lower, now near 22.7x, down about 2 points over the past month, which partly reflects the stock's 4% decline over that period. The dividend score ranks in the 96th percentile, a reminder that patient holders are being compensated while they wait.
Insider activity adds a mild cautionary note. The most consequential recent transaction was CEO Christopher Kubasik selling roughly 19,000 shares at $355 in late February, realizing $6.7 million. Several division presidents sold at similar levels in March. None of these were distress signals — they were sold at prices well above today's — but the pattern is a cluster of exec sales at levels roughly 20% above the current price, with no offsetting buying from senior leadership in the window since.
Earnings history gives a mixed picture of what July 23 might look like. The Q1 2026 print (reported May 11) produced a 3.3% one-day gain and held the move through five days. The Q4 2025 print went the other way, falling 2.5% on the day and extending to a 6.3% five-day loss. With the stock down 4% over the past month and notably underperforming peers this week, the July print is less about whether L3Harris can grow and more about whether the margin story in SAS and IMS has stabilized enough to justify closing the gap to its defense peers.
See the live data behind this article on ORTEX.
Open LHX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
